These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 25531136
1. PPARγ agonist-induced fluid retention depends on αENaC expression in connecting tubules. Fu Y, Gerasimova M, Batz F, Kuczkowski A, Alam Y, Sanders PW, Ronzaud C, Hummler E, Vallon V. Nephron; 2015; 129(1):68-74. PubMed ID: 25531136 [Abstract] [Full Text] [Related]
2. Reducing αENaC expression in the kidney connecting tubule induces pseudohypoaldosteronism type 1 symptoms during K+ loading. Poulsen SB, Praetorius J, Damkier HH, Miller L, Nelson RD, Hummler E, Christensen BM. Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F300-10. PubMed ID: 26582762 [Abstract] [Full Text] [Related]
3. Sodium and potassium balance depends on αENaC expression in connecting tubule. Christensen BM, Perrier R, Wang Q, Zuber AM, Maillard M, Mordasini D, Malsure S, Ronzaud C, Stehle JC, Rossier BC, Hummler E. J Am Soc Nephrol; 2010 Nov 15; 21(11):1942-51. PubMed ID: 20947633 [Abstract] [Full Text] [Related]
4. Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity. Vallon V, Hummler E, Rieg T, Pochynyuk O, Bugaj V, Schroth J, Dechenes G, Rossier B, Cunard R, Stockand J. J Am Soc Nephrol; 2009 Apr 15; 20(4):721-9. PubMed ID: 19158355 [Abstract] [Full Text] [Related]
5. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T. Proc Natl Acad Sci U S A; 2005 Jun 28; 102(26):9406-11. PubMed ID: 15956187 [Abstract] [Full Text] [Related]
6. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney. Borsting E, Cheng VP, Glass CK, Vallon V, Cunard R. Am J Physiol Renal Physiol; 2012 Mar 01; 302(5):F540-51. PubMed ID: 22169011 [Abstract] [Full Text] [Related]
7. PPARγ-induced stimulation of amiloride-sensitive sodium current in renal collecting duct principal cells is serum and insulin dependent. Chraïbi A, Renauld S. Cell Physiol Biochem; 2014 Mar 01; 33(3):581-93. PubMed ID: 24603133 [Abstract] [Full Text] [Related]
8. Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal nephron. Nesterov V, Dahlmann A, Krueger B, Bertog M, Loffing J, Korbmacher C. Am J Physiol Renal Physiol; 2012 Nov 01; 303(9):F1289-99. PubMed ID: 22933298 [Abstract] [Full Text] [Related]
9. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD. Nat Med; 2005 Aug 01; 11(8):861-6. PubMed ID: 16007095 [Abstract] [Full Text] [Related]
10. Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters. Zhou L, Liu G, Jia Z, Yang KT, Sun Y, Kakizoe Y, Liu M, Zhou S, Chen R, Yang B, Yang T. Am J Physiol Renal Physiol; 2013 Nov 15; 305(10):F1491-7. PubMed ID: 24005472 [Abstract] [Full Text] [Related]
11. Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase. Renauld S, Tremblay K, Ait-Benichou S, Simoneau-Roy M, Garneau H, Staub O, Chraïbi A. J Membr Biol; 2010 Aug 15; 236(3):259-70. PubMed ID: 20740360 [Abstract] [Full Text] [Related]
12. Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats. Tiwari S, Blasi ER, Heyen JR, McHarg AD, Ecelbarger CM. Pharmacol Res; 2008 May 15; 57(5):383-92. PubMed ID: 18468451 [Abstract] [Full Text] [Related]
13. Effect of Angiotensin II on ENaC in the Distal Convoluted Tubule and in the Cortical Collecting Duct of Mineralocorticoid Receptor Deficient Mice. Wu P, Gao ZX, Zhang DD, Duan XP, Terker AS, Lin DH, Ellison DH, Wang WH. J Am Heart Assoc; 2020 Apr 07; 9(7):e014996. PubMed ID: 32208832 [Abstract] [Full Text] [Related]
14. Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats. Song J, Knepper MA, Hu X, Verbalis JG, Ecelbarger CA. J Pharmacol Exp Ther; 2004 Feb 07; 308(2):426-33. PubMed ID: 14593089 [Abstract] [Full Text] [Related]
15. Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance. Rubera I, Loffing J, Palmer LG, Frindt G, Fowler-Jaeger N, Sauter D, Carroll T, McMahon A, Hummler E, Rossier BC. J Clin Invest; 2003 Aug 07; 112(4):554-65. PubMed ID: 12925696 [Abstract] [Full Text] [Related]
16. Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor. Ronzaud C, Loffing J, Bleich M, Gretz N, Gröne HJ, Schütz G, Berger S. J Am Soc Nephrol; 2007 Jun 07; 18(6):1679-87. PubMed ID: 17475815 [Abstract] [Full Text] [Related]
20. Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone. Artunc F, Sandulache D, Nasir O, Boini KM, Friedrich B, Beier N, Dicks E, Pötzsch S, Klingel K, Amann K, Blazer-Yost BL, Scholz W, Risler T, Kuhl D, Lang F. Pflugers Arch; 2008 May 07; 456(2):425-36. PubMed ID: 18172605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]